Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   
 

Abstract | Full HTML Article | PDF ecancer 12 818 / https://doi.org/10.3332/ecancer.2018.818

Review

Cystic brain metastases in ALK-rearranged non-small cell lung cancer

The central nervous system (CNS) is a common site of disease progression in patients with non-small-cell lung cancer (NSCLC) with anaplastic lymphoma kinase (ALK)-rearrangement treated with crizotinib. Cystic brain metastases (CBM) have been recently identified as one possible variant of this disease. An illustrative case report is presented along with a literature review performed in order to track relevant papers about CBM in ALK-rearranged NSCLC, including possible pathophysiology, differential diagnosis and treatment options for this condition. Three case reports have been published describing six ALK-rearranged NSCLC patients presenting with CBM, all of which were under treatment with crizotinib by the time of CBM diagnosis. Treatment with CNS-penetrating tyrosine kinase inhibitors (TKIs) resulted in CNS disease control in three of the six cases reported either as single therapy or in combination with radiation therapy (RT). Investigation of differential diagnoses of CBM might be necessary, which include inflammatory and demyelinating disorders, primary brain tumours and infectious diseases, especially neurocysticercosis that might mimic CBM images. Treatment options include RT, CNS-penetrating TKIs and invasive procedures, such as stereotactic drainage. Thus, CBM are associated with ALK-rearranged NSCLC, particularly in patients who use crizotinib and should prompt investigation of differential diagnosis. CNS-penetrating TKIs are effective in the control of solid brain metastases and also seem to be active in CBM as single therapy or in combination with RT.

Keywords: non-small cell lung cancer, anaplastic lymphoma kinase, cystic brain metastases, crizotinib, neurocysticercosis

Loading Article Metrics ... Please wait

Related articles

Review: Lung cancer patients have the highest malignancy-associated suicide rate in USA: a population-based analysis

Abstract | Full Article | PDF Published: 16 Aug 2018 / https://doi.org/10.3332/ecancer.2018.859

Case Report: Recurrent dermatofibrosarcoma protuberans: challenging a surgeon’s dexterity for the ‘tricky’ margins

Abstract | Full Article | PDF Published: 13 Aug 2018 / https://doi.org/10.3332/ecancer.2018.858

Policy: The understanding of healthcare workers on the content of palliative care policy in Shesilweni Swaziland: a qualitative study

Abstract | Full Article | PDF Published: 10 Aug 2018 / https://doi.org/10.3332/ecancer.2018.857

Case Report: Two cases of white globe appearance in non-cancerous stomach

Abstract | Full Article | PDF Published: 07 Aug 2018 / https://doi.org/10.3332/ecancer.2018.856

Research: Survival probabilities and trends for lip, oral cavity and oropharynx cancers in the Northern Region of Portugal in the period 2000–2009

Abstract | Full Article | PDF Published: 31 Jul 2018 / https://doi.org/10.3332/ecancer.2018.855



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation